Somatic mitochondrial mutations in melanoma resection specimens

Martin Deichmann1, Birgit Kahle, Axel Benner

  • 1Department of Dermatology, University Clinics of Heidelberg, D-69115 Heidelberg, Germany. martin_deichmann@med.uni-heidelberg.de

Insights

Ultraviolet radiation is linked to melanoma. Researchers found mitochondrial DNA alterations, particularly in (C)n tracts, in melanoma metastases, suggesting these changes may predict tumor progression and prognosis.

Area of Science:

  • Oncology
  • Genetics
  • Dermatology

Background:

  • Epidemiological data identify ultraviolet (UV) radiation as a primary environmental factor in melanoma development.
  • Mitochondrial DNA (mtDNA) is more susceptible to mutations than nuclear DNA.
  • UV-specific DNA mutations (C>T and CC>TT) are observed in skin cancers.

Purpose of the Study:

  • To investigate UV-specific DNA mutations (C>T and CC>TT) in mitochondrial DNA (mtDNA) of melanoma.
  • To analyze mutations in hypermutable (C)n tracts within the mtDNA displacement-loop (D-loop).
  • To assess the potential of mtDNA alterations for predicting melanoma progression and patient prognosis.

Main Methods:

  • Screening of 69 melanoma resection specimens for mtDNA D-loop mutations.
  • Utilizing polymerase chain reaction (PCR) and single-strand conformation polymorphism (SSCP) electrophoresis.
  • DNA cloning and sequencing to identify specific mutations and alterations.

Main Results:

  • mtDNA D-loop fragment alterations were detected in 12% of primary melanomas and 20% of metastases.
  • Microsatellite instability (MSI) in mtDNA (C)n tracts was observed in 9 out of 11 cases with alterations.
  • Only 4 UV-specific C>T mutations were found; no CC>TT mutations were detected.
  • Alterations in (C)n tracts were present in primary melanomas that subsequently metastasized, but absent in non-metastasizing melanomas.

Conclusions:

  • mtDNA D-loop alterations, particularly in (C)n tracts, are present in melanoma.
  • Microsatellite instability in mtDNA may indicate genomic imbalance during tumor progression.
  • These somatic mtDNA changes could serve as a prognostic marker for melanoma patients.